Table 4.
Reporting system of thyroid FNA cytology
| Country | Before TBSRTC | After TBSRTC |
|---|---|---|
| China | No data | TBSRTC is the most widely accepted. |
| India | No data | TBSRTC is the most widely used. |
| Japan | General Rules for the Description of Thyroid Cancer (GRDTC): adapted from the 1996 Papanicolaou Society recommendations; published by the Japanese Society of Thyroid Surgery in 2005 and updated in 2006 | GRDTC system is widely used. |
| Japanese system for thyroid FNA cytology published by the Japan Thyroid Association (JTA) in 2013: used in several high-vdume thyroid surgery centers | ||
| TBSRTC is rarely used. | ||
| Korea | Not standardized and varied, but mostly followed guidelines of the Papanicolaou Society of Cytopathology | TBSRTC is the most widely accepted. |
| Philippines | Based on histopathologic terminology of thyroid disorder | TBSRTC is the most widely used. |
| Taiwan | All investigators used different diagnostic categories. | TBSRTC or the 6-tier system corresponding to each Bethesda category |
| Thailand | Not standardized and varied, e.g., thyroid FNA reporting was based on specific diagnosis of the lesions. | TBSRTC is the most widely accepted. |
FNA, fine-needle aspiration; TBSRTC, The Bethesda System for Reporting Thyroid Cytopathology.